Transcode Net Tangible Assets vs Common Stock Analysis

RNAZ Stock  USD 7.89  0.56  6.63%   
Transcode Therapeutics financial indicator trend analysis is much more than just breaking down Transcode Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Transcode Therapeutics is a good investment. Please check the relationship between Transcode Therapeutics Net Tangible Assets and its Common Stock accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Transcode Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Transcode Stock please use our How to Invest in Transcode Therapeutics guide.

Net Tangible Assets vs Common Stock

Net Tangible Assets vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Transcode Therapeutics Net Tangible Assets account and Common Stock. At this time, the significance of the direction appears to have weak relationship.
The correlation between Transcode Therapeutics' Net Tangible Assets and Common Stock is 0.36. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Common Stock in the same time period over historical financial statements of Transcode Therapeutics, assuming nothing else is changed. The correlation between historical values of Transcode Therapeutics' Net Tangible Assets and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of Transcode Therapeutics are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Net Tangible Assets i.e., Transcode Therapeutics' Net Tangible Assets and Common Stock go up and down completely randomly.

Correlation Coefficient

0.36
Relationship DirectionPositive 
Relationship StrengthVery Weak

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Common Stock

Most indicators from Transcode Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Transcode Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Transcode Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Transcode Stock please use our How to Invest in Transcode Therapeutics guide.Selling General Administrative is likely to rise to about 7.5 B in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 11.7 M in 2024.
 2021 2022 2023 2024 (projected)
Depreciation And Amortization42.5K98.6K516.7K304.6K
Interest Income664.020.4K14.8K7.9K

Transcode Therapeutics fundamental ratios Correlations

0.830.57-0.830.870.650.080.67-0.60.920.53-0.580.980.540.690.21-0.010.850.54-0.420.550.110.760.480.390.43
0.830.52-0.830.870.64-0.240.67-0.250.90.47-0.530.810.530.860.640.420.950.53-0.610.680.10.930.450.150.42
0.570.52-0.340.590.980.360.97-0.570.590.99-0.990.520.980.33-0.13-0.180.520.98-0.170.22-0.380.250.980.560.96
-0.83-0.83-0.34-0.96-0.390.46-0.440.59-0.95-0.240.28-0.79-0.24-0.95-0.390.02-0.74-0.240.84-0.920.17-0.71-0.180.16-0.11
0.870.870.59-0.960.63-0.290.67-0.670.990.5-0.530.830.490.920.29-0.070.780.49-0.780.85-0.260.690.450.030.38
0.650.640.98-0.390.630.371.0-0.490.650.98-0.990.620.980.380.0-0.030.630.98-0.190.22-0.220.410.970.620.95
0.08-0.240.360.46-0.290.370.31-0.08-0.20.45-0.450.150.45-0.61-0.57-0.2-0.110.450.71-0.720.34-0.180.470.90.5
0.670.670.97-0.440.671.00.31-0.510.690.96-0.980.640.970.430.03-0.020.660.97-0.250.28-0.230.440.950.580.94
-0.6-0.25-0.570.59-0.67-0.49-0.08-0.51-0.63-0.510.47-0.57-0.4-0.410.490.77-0.18-0.40.45-0.50.53-0.01-0.43-0.16-0.34
0.920.90.59-0.950.990.65-0.20.69-0.630.52-0.560.90.520.890.310.00.830.52-0.720.79-0.130.760.470.140.41
0.530.470.99-0.240.50.980.450.96-0.510.52-1.00.50.990.23-0.16-0.150.490.99-0.050.1-0.310.221.00.650.98
-0.58-0.53-0.990.28-0.53-0.99-0.45-0.980.47-0.56-1.0-0.55-1.0-0.260.090.07-0.56-1.00.06-0.110.23-0.31-0.99-0.67-0.98
0.980.810.52-0.790.830.620.150.64-0.570.90.5-0.550.510.630.160.00.80.51-0.40.480.220.780.450.460.4
0.540.530.98-0.240.490.980.450.97-0.40.520.99-1.00.510.24-0.05-0.020.561.0-0.030.08-0.210.310.990.670.99
0.690.860.33-0.950.920.38-0.610.43-0.410.890.23-0.260.630.240.570.160.750.24-0.90.96-0.250.720.18-0.310.13
0.210.64-0.13-0.390.290.0-0.570.030.490.31-0.160.090.16-0.050.570.870.64-0.05-0.370.430.30.73-0.13-0.33-0.1
-0.010.42-0.180.02-0.07-0.03-0.2-0.020.770.0-0.150.070.0-0.020.160.870.46-0.020.04-0.040.590.6-0.1-0.02-0.02
0.850.950.52-0.740.780.63-0.110.66-0.180.830.49-0.560.80.560.750.640.460.56-0.40.540.190.910.480.260.47
0.540.530.98-0.240.490.980.450.97-0.40.520.99-1.00.511.00.24-0.05-0.020.56-0.030.08-0.210.310.990.670.99
-0.42-0.61-0.170.84-0.78-0.190.71-0.250.45-0.72-0.050.06-0.4-0.03-0.9-0.370.04-0.4-0.03-0.950.42-0.450.00.510.06
0.550.680.22-0.920.850.22-0.720.28-0.50.790.1-0.110.480.080.960.43-0.040.540.08-0.95-0.430.510.04-0.5-0.03
0.110.1-0.380.17-0.26-0.220.34-0.230.53-0.13-0.310.230.22-0.21-0.250.30.590.19-0.210.42-0.430.45-0.280.41-0.23
0.760.930.25-0.710.690.41-0.180.44-0.010.760.22-0.310.780.310.720.730.60.910.31-0.450.510.450.210.180.2
0.480.450.98-0.180.450.970.470.95-0.430.471.0-0.990.450.990.18-0.13-0.10.480.990.00.04-0.280.210.660.99
0.390.150.560.160.030.620.90.58-0.160.140.65-0.670.460.67-0.31-0.33-0.020.260.670.51-0.50.410.180.660.68
0.430.420.96-0.110.380.950.50.94-0.340.410.98-0.980.40.990.13-0.1-0.020.470.990.06-0.03-0.230.20.990.68
Click cells to compare fundamentals

Transcode Therapeutics Account Relationship Matchups

Transcode Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Current Liabilities62.9K404.9K2.5M4.3M3.5M2.0M
Net Tangible Assets(1.1M)(3.4M)20.4M3.2M3.7M4.1M
Retained Earnings(1.1M)(3.5M)(10.3M)(27.9M)(46.4M)(44.1M)
Other Stockholder Equity7.7K65.9K30.7M31.1M48.1M50.5M
Total Current Assets204.5K831.2K22.7M7.4M4.5M6.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Transcode Stock Analysis

When running Transcode Therapeutics' price analysis, check to measure Transcode Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transcode Therapeutics is operating at the current time. Most of Transcode Therapeutics' value examination focuses on studying past and present price action to predict the probability of Transcode Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transcode Therapeutics' price. Additionally, you may evaluate how the addition of Transcode Therapeutics to your portfolios can decrease your overall portfolio volatility.